Np mrd loader

Record Information
Version2.0
Created at2025-04-08 15:51:01 UTC
Updated at2025-07-24 18:35:52 UTC
NP-MRD IDNP0350921
Natural Product DOIhttps://doi.org/10.57994/3906
Secondary Accession NumbersNone
Natural Product Identification
Common NameComp3
Description Comp3 was first documented in 2021 (PMID: 33495861). Based on a literature review a small amount of articles have been published on Comp3 (PMID: 37702159) (PMID: 36816262) (PMID: 37513188) (PMID: 38822803).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC22H28N6O2
Average Mass408.5060 Da
Monoisotopic Mass408.22737 Da
IUPAC NameN-[(3S,6S,8aS)-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methyl}-1,4-dioxo-octahydropyrrolo[1,2-a]pyrazin-6-yl]guanidine
Traditional NameN-[(3S,6S,8aS)-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methyl}-1,4-dioxo-hexahydropyrrolo[1,2-a]pyrazin-6-yl]guanidine
CAS Registry NumberNot Available
SMILES
CC(C)(C=C)C1=C(C[C@@H]2NC(=O)[C@@H]3CC[C@@H](NC(N)=N)N3C2=O)C2=C(N1)C=CC=C2
InChI Identifier
InChI=1S/C22H28N6O2/c1-4-22(2,3)18-13(12-7-5-6-8-14(12)25-18)11-15-20(30)28-16(19(29)26-15)9-10-17(28)27-21(23)24/h4-8,15-17,25H,1,9-11H2,2-3H3,(H,26,29)(H4,23,24,27)/t15-,16-,17-/m0/s1
InChI KeyWVLIWDCKPOTOKZ-ULQDDVLXSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
HSQC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
ROESY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental)niwakanji0218@gmail.comUniversity of California, Los AngelesKanji Niwa2025-04-08View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP1.06ChemAxon
pKa (Strongest Acidic)11.65ChemAxon
pKa (Strongest Basic)11.1ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area127.1 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity124.69 m³·mol⁻¹ChemAxon
Polarizability44.01 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Naskar A, Bhanja KK, Roy RK, Patra N: Structural insight into G2019S mutated LRRK2 kinase and brain-penetrant type I inhibitor complex: a molecular dynamics approach. J Biomol Struct Dyn. 2024;42(19):10129-10149. doi: 10.1080/07391102.2023.2255675. Epub 2023 Sep 13. [PubMed:37702159 ]
  2. Rampogu S, Shaik B, Kim JH, Jung TS, Ha MW, Lee KW: Explicit molecular dynamics simulation studies to discover novel natural compound analogues as Mycobacterium tuberculosis inhibitors. Heliyon. 2023 Jan 30;9(2):e13324. doi: 10.1016/j.heliyon.2023.e13324. eCollection 2023 Feb. [PubMed:36816262 ]
  3. Khan S, Fakhar Z, Ahmad A: Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes. J Mol Model. 2021 Jan 25;27(2):49. doi: 10.1007/s00894-021-04682-8. [PubMed:33495861 ]
  4. Yin Z, Liu S, Yang X, Chen M, Du J, Liu H, Yang L: LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study. Molecules. 2023 Jul 10;28(14):5315. doi: 10.3390/molecules28145315. [PubMed:37513188 ]
  5. Naskar A, Roy RK, Srivastava D, Patra N: Decoding Inhibitor Egression from Wild-Type and G2019S Mutant LRRK2 Kinase: Insights into Unbinding Mechanisms for Precision Drug Design in Parkinson's Disease. J Phys Chem B. 2024 Jul 18;128(28):6657-6669. doi: 10.1021/acs.jpcb.4c00335. Epub 2024 Jun 1. [PubMed:38822803 ]